scholarly journals Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer

2014 ◽  
Vol 17 (7) ◽  
pp. A735 ◽  
Author(s):  
Nguyen TTC ◽  
Nguyen TTT
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Early Stage ◽  
Cost Effectiveness Analysis ◽  
Her2 Positive ◽  
Adjuvant Trastuzumab ◽  
Her2 Positive Breast Cancer ◽  
Trastuzumab Therapy ◽  
Effectiveness Analysis ◽  
Positive Breast Cancer

scholarly journals Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer

2019 ◽  
Vol 25 (10) ◽  
pp. 1133-1139 ◽  
Author(s):  
Naomi R.M. Schwartz ◽  
Meghan R. Flanagan ◽  
Joseph B. Babigumira ◽  
Lotte M. Steuten ◽  
Joshua A. Roth
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Early Stage ◽  
Cost Effectiveness Analysis ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Effectiveness Analysis ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document